Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome
- Conditions
- Post COVID-19 Syndrome
- First Posted Date
- 2021-03-15
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Registration Number
- NCT04798066
- Locations
- ๐บ๐ธ
Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States
Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.
- Conditions
- Parkinson Disease
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Registration Number
- NCT04772378
- Locations
- ๐บ๐ธ
Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States
Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.
- Conditions
- Chronic Pain
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Registration Number
- NCT04711811
- Locations
- ๐บ๐ธ
Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States
Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.
- Conditions
- Knee Pain ChronicOsteo Arthritis Knee
- First Posted Date
- 2020-10-27
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Registration Number
- NCT04604288
- Locations
- ๐บ๐ธ
Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States
Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis
- Conditions
- Amyotrophic Lateral Sclerosis
- First Posted Date
- 2020-08-17
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Registration Number
- NCT04514952
- Locations
- ๐บ๐ธ
River Oaks Hospital and Clinics, Houston, Texas, United States
Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19
Phase 2
Terminated
- Conditions
- COVID-19
- Interventions
- Biological: HB-adMSCOther: Placebo
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Target Recruit Count
- 48
- Registration Number
- NCT04362189
- Locations
- ๐บ๐ธ
River Oaks Hospital and Clinics, Houston, Texas, United States
๐บ๐ธUnited Memorial Medical Center, Houston, Texas, United States
A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.
Phase 2
Completed
- Conditions
- COVID-19
- Interventions
- Biological: HB-adMSCsOther: Placebos
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Target Recruit Count
- 53
- Registration Number
- NCT04348435
- Locations
- ๐บ๐ธ
Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States
A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19
Phase 2
Completed
- Conditions
- COVID-19
- Interventions
- Biological: HB-adMSCs
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Target Recruit Count
- 51
- Registration Number
- NCT04349631
- Locations
- ๐บ๐ธ
Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease
Phase 1
Withdrawn
- Conditions
- Alzheimer Disease
- Interventions
- Biological: HB-adMSCs
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Registration Number
- NCT04228666
- Locations
- ๐บ๐ธ
Clinical Trial Network, Houston, Texas, United States
Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury
- Conditions
- Spinal Cord Injuries
- First Posted Date
- 2019-08-22
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Hope Biosciences Stem Cell Research Foundation
- Registration Number
- NCT04064957
- Locations
- ๐บ๐ธ
Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath